Obexelimab in Systemic Lupus Erythematosus With Exploration of Response Based on Gene Pathway Co‐Expression Patterns: A Double‐Blind, Randomized, Placebo‐Controlled, Phase 2 Trial.

Published in:

Arthritis & Rheumatology, 2023, v. 75, n. 12, p. 2185, doi. 10.1002/art.42652

By:

• Merrill, Joan T.;
• Guthridge, Joel;
• Smith, Miles;
• June, Joshua;
• Koumpouras, Fotios;
• Machua, Wambui;
• Askanase, Anca;
• Khosroshahi, Arezou;
• Sheikh, Saira Z.;
• Rathi, Gaurav;
• Burington, Bart;
• Foster, Paul;
• Matijevic, Mark;
• Arora, Sujata;
• Wang, Xiaodong;
• Gao, Minggeng;
• Wax, Stephen;
• James, Judith A.;
• Zack, Debra J.

Publication type:

Article